Karyometry in the early detection and chemoprevention of intraepithelial lesions

European Journal of Cancer

Volumn 41, Issue 13, 2005, Pages 1875-1888

  Ranger Moore, J ^a   Alberts, D S ^a   Montironi, R ^b   Garcia, F ^a   Davis, J ^a   Frank, D ^a   Brewer, M ^a   Mariuzzi, G M ^c   Bartels, H G ^a   Bartels, P H ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

Chemoprevention; Intraepithelial lesions; Karyometry; Measurement of efficacy; Pre neoplastic lesions; Progression curves

Indexed keywords

EFLORNITHINE; PLACEBO; RETINOL; TUMOR MARKER;

ACTINIC KERATOSIS; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CANCER PREVENTION; CANCER RISK; CARCINOMA IN SITU; CELL HETEROGENEITY; CLINICAL TRIAL; COLON ADENOMA; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; HISTOPATHOLOGY; HUMAN; KARYOMETRY; NEOPLASM; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

EID: 27644433888     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.07.002     Document Type: Article

References (47)

1. Grundmann E, Stein P. Untersuchungen ueber die Kernstrukturen in normalen Geweben und im Carcinom. Beitr Pathol Anat 1968, 125, 54-76.
2. Harbers E, Sandritter W. Gesteigerte Heterchromatisierung als pathogenetisches Prinzip. Deutsche Med. Wochenschrift 1968, 93, 269-271.
3. Bartels PH, Montironi R, Hamilton PW, et al. Nuclear chromatin texture in prostatic lesions. II. PIN and malignancy associated changes. Anal Quant Cytol Histol 1998, 20(5), 397-406.
4. Susnik B, Worth A, LeRiche J, et al. Malignancy associated changes in the breast. Changes in chromatin distribution in epithelial cells in normal appearing tissue adjacent to cancer. Anal Quant Cytol Histol 1995, 17, 62-68.
5. King EB, Kromout LK, Chew KL, et al. Analytic studies of foam cells from breast cancer precursors. Cytometry 1984, 5, 124-130.
6. Anderson NHJ, Kirk SJ, Frank D, et al. Malignancy-associated changes in lactiferous duct epithelium. Anal Quant Cytol Histol 2003, 25(2), 63-72.
7. Brewer MA, Ranger-Moore J, Greene MH, et al. Preneoplastic changes in ovarian tissues. Anal Quant Cytol Histol 2004, 26(4), 207-216.
8. Brewer MA, Ranger-Moore J, Baruche A, et al. Exploratory study of ovarian intraepithelial neoplasia. Cancer Epidem Biomar Prevent 2005, 14(2), 299-305.
9. Wied GL, Bartels PH, Bibbo M, et al. Cytomorphometric markers for uterine cancer in intermediate cells. Anal Quant Cytol Histol 1980, 2(4), 257-263.
10. Bibbo M, Bartels PH, Sychra JJ, et al. Chromatin appearance in intermediate cells from patients with uterine cancer. Acta Cytol 1981, 25(1), 23-28.
11. Burger GJU, Rodenacker C. Changes in benign cell populations in cases of cervical cancer and its precursors. Anal Quant Cytol Histol 1981, 3, 261-271.
12. Vooijs PG, Oud PS, Zahniser DJ, et al. Chromatin measurements in Feulgen stained intermediate cells from normal and abnormal cervical smears. Analyt Quant Cytol 1982, 4, 154.
13. Reinhardt ER, Lenz R, Greiner W, et al. Diagnostic relevance of visually nonsuspect cells for cancer diagnosis. Anal Quant Cytol Histol 1982, 4, 157.
14. Kwikkel HJ, Timmers T, Boone ME, et al. Relation of quantitative features of visually normal intermediate cells in cervical intraepithelial neoplasis I and II smears to progression or non-progression of the lesion. Anal Quant Cytol Histol 1987, 9, 405-410.
15. Haroske G, Bernander ST, Koenig R, et al. Application of malignancy associated changes of the cervical epithelium in a hierarchic classification concept. Anal Cell Path 1990, 2, 189-198.
16. Montag AG, Bartels PH, Lerma-Puertas E, et al. Karyometric marker features in tissue adjacent to in situ cervical carcinomas. Anal Quant Cytol Histol 1989, 11(4), 275-280.
17. Bibbo M, Montag AG, Lerma-Puertas E, et al. Karyometric marker features in tissue adjacent to invasive cervical carcinomas. Anal Quant Cytol Histol 1989, 11(4), 281-285.
18. MacAulay C, Lam S, Payner PW, et al. Malignancy associated changes in bronchial epithelial cells in biopsy specimens. Anal Quant Cytol Histol 1995, 17, 55-71.
19. Montag AG, Bartels PH, Dytch HE, et al. Karyometric features in nuclei near colonic adenocarcinoma. Statistical analysis. Anal Quant Cytol Histol 1991, 13(3), 159-167.
20. Ranger-Moore J, Frank D, Lance P, et al. Karyometry in rectal mucose of patients with previous colorectal adenomas. Anal Quant Cytol Histol 2005, 27, 134-142.
21. daSilva VD, Prolla JC, Sharma P, et al. Karyometry in Barrett's Esophagus. Anal Quant Cytol Histol 2001, 23(1), 40-46.
22. Bibbo M, Bartels PH, Galera-Davidson H, et al. Markers for malignancy in the nuclear texture of histologically normal tissue from patients with thyroid tumors. Anal Quant Cytol Histol 1986, 8(2), 168-176.
23. Lerma-Puertas E, Galera-Davidson H, Bartels PH, et al. Karyometric marker features in fine needle aspirates of follicular adenoma of the thyroid. Anal Quant Cytol Histol 1990, 12(4), 223-228.
24. Montironi R, Scarpelli M, Mazzucchelli R, et al. Subvisual chromatin changes are detected in the histologically normal urothelium in patients with synchronous papillary carcinoma. Hum Pathol 2003, 34(9), 893-901.
25. Bartels PH, Montironi R, Hamilton PW, et al. Nuclear chromatin texture in prostatic lesions. I. PIN and adenocarcinoma. Anal Quant Cytol Histol 1998, 20(5), 389-396.
26. Calaluce R, Kunkel M, Watts G, et al. Liminin-5-mediated gene expression in human prostate carcinoma cells. Mol Carcinogen 2001, 30(2), 119-129.
27. Bartels PH, daSilva VD, Montironi R, et al. Chromatin texture signatures in nuclei from prostate lesions. Anal Quant Cytol Histol 1998, 20(5), 407-416.
28. Bartels PH, Ranger-Moore J, Bartels HG, et al. Second order discriminant analysis in chemopreventive efficacy measurement. Anal Quant Cytol Histol 2005, 27, 15-26.
29. Tsybrovskyy O, Berghold A. Application of multilevel models to morphometric data. Part 1. Linear models and hypothesis testing. Anal Cell Pathol 2003, 25, 173-185.
30. Tsybrovskyy O, Berghold A. Application of multilevel models to morphometric data. Part 2. Correlations. Anal Cell Pathol 2003, 25, 187-191.
31. Ranger-Moore J, Bozzo P, Alberts DS, et al. Karyometry of nuclei from actinic keratosis and squamous cell cancer of the skin. Anal Quant Cytol Histol 2003, 25(6), 353-361.
32. Wolfe P, Murphy J, McGinley J, et al. Using nuclear morphometry to discriminate the tumorigenic potential of cells: a comparison of statistical methods. Cancer Epidem Biomar Prevent 2004, 13(6), 976-988.
33. Raudenbush SW. Statistical analysis and optimal design in cluster randomized trials. Psychol Meth 1997, 2(2), 173-185.
34. Garret JM. Sample size estimation for cluster designed samples. Stat Tech Bull 2001, 60, 41-45.
35. Bartels PH, Garcia FAR, Davis J, et al. Progression curves for endometrial lesions. Anal Quant Cytol Histol 2001, 23, 1-8.
36. Mariuzzi L, Mombello A, Rucco V, et al. Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancers. Adv Clin Path 2000, 4, 87-97.
37. Bartels PH, Thompson D, Montironi R, et al. Digital knowledge and diagnostic information. J Histotechnol 2000, 23(3), 183-190.
38. Bozzo PD, Alberts DS, Vaught L, et al. Measurement of chemopreventive efficacy in skin biopsies. Anal Quant Cytol Histol 2001, 23, 300-312.
39. Alberts DS, Ranger-Moore J, Einspahr J, et al. Safety and efficacy of dose-intensive oral vitamin A in subjects with sun-damaged skin, Clin Cancer Res 2004, 10(6), 1875-1880.
40. Bartels PH, Ranger-Moore J, Stratton MS, et al. Statistical Analysis of chemopreventive efficacy of vitamin A in sun-exposed, normal skin. Anal Quant Cytol Histol 2002, 24(4), 185-197.
41. Swed FS, Eisenhart C. Tables for testing randomness of grouping in a sequence of alternatives. Annal Math Stat 1943, 14, 66-87., Table II.
42. Garcia F, Davis J, Alberts DS, et al. A karyometric approach to the characterization of atypical endometrial hyperplasia with and without co-ocurring adenocarcinoma. Anal Quant Cytol Histol 2003, 25, 246-339.
43. McClellan RP. Optimization and stochastic approximation techniques applied to unsupervised learning. Master's thesis, Tucson: University of Arizona, 1971.
44. Bartels PH, Olson GB. Computer analysis of lymphocyte images. In Catsimpoolas N, ed. Methods of cell separation. New York, Plenum Press, 1980. pp. 1-99.
45. Montironi R, Scarpelli M, Mazzucchelli R, et al. Subvisual changes in chromatin organization state are detected by karyometry in the histologically normal urothelium in patients with synchronous papillary carcinoma. Hum Pathol 2003, 34(9), 893-901.
46. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989, 81(24), 1879-1886.
47. Moon TE, Levine N, Cartmel B, et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Cancer Epidem Biomar Prevent 1997, 6(11), 949-956.